Averin Capital Acquisition
ACAAW · NASDAQ
ACAAW key statistics
- Market cap
- —
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 16.48K
- Volume
- 6.60K
- Open price
- $0.52
- High today
- $0.6656
- Low today
- $0.52
- 52 Week high
- $0.89
- 52 Week low
- $0.40
Averin Capital Acquisition (ACAAW) at a glance
Averin Capital Acquisition (ACAAW) last traded at $0.6656, with a price-to-earnings ratio of 0.00.
Today the stock has traded between $0.52 and $0.6656. The current price is 28.0% above the day's low and 0.0% below its high.
Volume so far is 6.60K shares, below the average of 16.48K shares a day.
Over the past year Averin Capital Acquisition has ranged from $0.40 to $0.89, and now sits 54% of the way up that range.
Most active stocks
Highest trading volume today
- RDARRaadr$0.0002+0.00%
- DVLTDatavault AI$0.0879+31.19%
- RCTRedCloud Holdings$0.0617−5.95%
- TIPSTianrong Internet Products & Services$0.0014+27.27%
- GTVHGolden Triangle Ventures$0.0002+0.00%
- AITXArtificial Intelligence Technology Solutions$0.0005−43.75%
- CDTCDT Equity$0.083+3.75%
- EARIEntertainment Arts Research$0.0002+0.00%
- NBNDNetBrands$0.0006−14.29%
- NVDGraniteShares ETF Trust$4.01+2.04%
- STLAStellantis N.V$4.68+13.04%
- NTRRNeutra$0.0002+0.00%
Newly listed
Companies that went public in the past six weeks
- SCQCUSPACCircle Acquisition$9.97−0.05%
- LYCALycia Therapeutics$25.05−4.06%
- DAVIDAVION HEALTHCARE$3.29+9.67%
- TCXBTCGX Acquisition Corp. II$10.27−0.10%
- CTYCITY THERAPEUTICS$21.65+3.79%
- IAMIambic Therapeutics$14.78+5.57%
- AMROAmaero$5.86−2.98%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.23−0.49%
- TRXBTRex Bio$14.43+4.64%
- RTSNRetension Pharmaceuticals$13.09−3.18%
- PAXGUPine Tree Acquisition$10.02+0.20%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.